|
Market Closed -
Nasdaq
16:00:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 24.92 USD | -0.12% |
|
+2.13% | +50.94% |
| 08-07 | UBS Adjusts Price Target on Denali Therapeutics to $34 From $25, Maintains Buy Rating | MT |
| 08-07 | Wedbush Adjusts PT on Denali Therapeutics to $27 From $26, Maintains Outperform Rating | MT |
| Market Cap | 3.98B 3.41B 3.19B 2.92B 5.48B 381B 5.56B 37.72B 14.71B 191B 14.96B 14.63B 633B | P/E 2026 * |
-11x | P/E 2027 * | -10.8x |
|---|---|---|---|---|---|
| Enterprise Value | 3.27B 2.81B 2.62B 2.4B 4.51B 313B 4.57B 31.01B 12.09B 157B 12.3B 12.03B 521B | EV / Sales 2026 * |
53.8x | EV / Sales 2027 * | 25x |
| Free-Float |
90.03% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Denali Therapeutics Inc.
| 1 day | -0.12% | ||
| 1 week | +2.13% | ||
| Current month | +8.25% | ||
| 1 month | +4.57% | ||
| 3 months | +29.12% | ||
| 6 months | +23.43% | ||
| Current year | +50.94% |
| 1 week | 24.01 |  | 25.7 |
| 1 month | 22.63 | | 25.74 |
| Current year | 15.34 | | 27.3 |
| 1 year | 12.58 | | 27.3 |
| 3 years | 10.57 | | 33.33 |
| 5 years | 10.57 | | 56.8 |
| 10 years | 10.57 | | 93.94 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Schuth
DFI | Director of Finance/CFO | 52 | 2022-04-30 |
Ryan Watts
CEO | Chief Executive Officer | 50 | 2015-07-31 |
Peter Chin
CTO | Chief Tech/Sci/R&D Officer | 58 | 2025-11-05 |
| Director | Title | Age | Since |
|---|---|---|---|
Ryan Watts
BRD | Director/Board Member | 50 | 2015-02-28 |
Jay Flatley
BRD | Director/Board Member | 73 | 2015-03-31 |
David Schenkein
BRD | Director/Board Member | 68 | 2015-03-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/12/26 | Don | Founder | -32,220 | 0.0203% | ||
| 8/11/26 | Sell | Founder | -2,857 | 0.0018% | ||
| 6/3/26 | Free | Director | 25,634 | 0.0162% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.12% | +2.13% | +63.62% | +7.09% | 3.99B | |
| -3.00% | +0.33% | +77.39% | +109.41% | 73.96B | |
| +1.90% | +23.53% | +56.60% | +97.76% | 64.66B | |
| +0.55% | +1.64% | -5.15% | +471.68% | 27.32B | |
| +5.12% | +25.22% | +5.24% | -0.82% | 27.86B | |
| +2.74% | +11.55% | +66.56% | +27.34% | 25.97B | |
| +0.47% | +6.22% | +39.36% | -12.38% | 19.98B | |
| +1.82% | -3.11% | +245.72% | +423.83% | 17.84B | |
| +0.94% | +2.38% | +24.83% | +552.12% | 16.24B | |
| +0.73% | +5.54% | +39.71% | +153.07% | 13.3B | |
| Average | +1.12% | +7.07% | +61.39% | +182.91% | 29.11B | |
| Weighted average by Cap. | +0.67% | +8.66% | +60.02% | +159.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 60.84M 52.12M 48.77M 44.64M 83.78M 5.82B 84.88M 576M 225M 2.92B 228M 223M 9.67B | 129M 111M 104M 94.78M 178M 12.36B 180M 1.22B 477M 6.21B 485M 475M 20.54B |
| Net income | -452M -387M -362M -332M -622M -43.25B -631M -4.28B -1.67B -21.73B -1.7B -1.66B -71.86B | -453M -388M -363M -332M -624M -43.36B -632M -4.29B -1.67B -21.78B -1.7B -1.66B -72.04B |
| Net Debt | -708M -607M -568M -520M -975M -67.78B -988M -6.71B -2.62B -34.05B -2.66B -2.6B -113B | -749M -641M -600M -549M -1.03B -71.63B -1.04B -7.09B -2.76B -35.98B -2.81B -2.75B -119B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | US$24.92 | -0.12% | 680,935 |
| 26-08-20 | US$24.95 | -2.88% | 976,848 |
| 26-08-19 | US$25.69 | +5.68% | 1,150,287 |
| 26-08-18 | US$24.31 | -0.16% | 1,099,616 |
| 26-08-17 | US$24.35 | -0.20% | 1,003,238 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DNLI Stock
Select your edition
All financial news and data tailored to specific country editions
